135 related articles for article (PubMed ID: 21659721)
1. Serum insulin, cortisol, leptin, neuropeptide Y, galanin and ghrelin levels in epileptic children receiving valproate.
Cansu A; Serdaroglu A; Camurdan O; Hırfanoğlu T; Cinaz P
Horm Res Paediatr; 2011; 76(1):65-71. PubMed ID: 21659721
[TBL] [Abstract][Full Text] [Related]
2. Serum insulin, cortisol, leptin, neuropeptide Y, galanin and ghrelin levels in epileptic children receiving oxcarbazepine.
Cansu A; Serdaroglu A; Cinaz P
Eur J Paediatr Neurol; 2011 Nov; 15(6):527-31. PubMed ID: 21703891
[TBL] [Abstract][Full Text] [Related]
3. The effects of valproate and topiramate use on serum insulin, leptin, neuropeptide Y and ghrelin levels in epileptic children.
Çiçek NP; Kamaşak T; Serin M; Okten A; Alver A; Cansu A
Seizure; 2018 May; 58():90-95. PubMed ID: 29679911
[TBL] [Abstract][Full Text] [Related]
4. Plasma leptin, neuropeptide Y, ghrelin, and adiponectin levels and carotid artery intima media thickness in epileptic children treated with valproate.
Tokgoz H; Aydin K; Oran B; Kiyici A
Childs Nerv Syst; 2012 Jul; 28(7):1049-53. PubMed ID: 22645062
[TBL] [Abstract][Full Text] [Related]
5. Serum insulin, leptin, and neuropeptide y levels in epileptic children treated with valproate.
Aydin K; Serdaroglu A; Okuyaz C; Bideci A; Gucuyener K
J Child Neurol; 2005 Oct; 20(10):848-51. PubMed ID: 16417885
[TBL] [Abstract][Full Text] [Related]
6. The effect of topiramate on body weight and ghrelin, leptin, and neuropeptide-Y levels of prepubertal children with epilepsy.
Ozcelik AA; Serdaroglu A; Bideci A; Arhan E; Soysal Ş; Demir E; Gücüyener K
Pediatr Neurol; 2014 Aug; 51(2):220-4. PubMed ID: 25079570
[TBL] [Abstract][Full Text] [Related]
7. The role of ghrelin in weight gain and growth in epileptic children using valproate.
Gungor S; Yücel G; Akinci A; Tabel Y; Ozerol IH; Yologlu S
J Child Neurol; 2007 Dec; 22(12):1384-8. PubMed ID: 18174556
[TBL] [Abstract][Full Text] [Related]
8. States of serum leptin and insulin in children with epilepsy: risk predictors of weight gain.
Hamed SA; Fida NM; Hamed EA
Eur J Paediatr Neurol; 2009 May; 13(3):261-8. PubMed ID: 18586538
[TBL] [Abstract][Full Text] [Related]
9. The effects of topiramate and valproate therapy on insulin, c-peptide, leptin, neuropeptide Y, adiponectin, visfatin, and resistin levels in children with epilepsy.
Sonmez FM; Zaman D; Aksoy A; Deger O; Aliyazicioglu R; Karaguzel G; Fazlioglu K
Seizure; 2013 Dec; 22(10):856-61. PubMed ID: 23937963
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.
Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Kapliński A; Roguski K; Płonowski A
Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of appetite-stimulating hormones in prepubertal children with epilepsy during topiramate treatment.
Okuyaz C; Kursel O; Komur M; Tamer L
Pediatr Neurol; 2012 Dec; 47(6):423-6. PubMed ID: 23127262
[TBL] [Abstract][Full Text] [Related]
12. The effect of leptin, ghrelin, and neuropeptide-Y on serum Tnf-Α, Il-1β, Il-6, Fgf-2, galanin levels and oxidative stress in an experimental generalized convulsive seizure model.
Oztas B; Sahin D; Kir H; Eraldemir FC; Musul M; Kuskay S; Ates N
Neuropeptides; 2017 Feb; 61():31-37. PubMed ID: 27522536
[TBL] [Abstract][Full Text] [Related]
13. Changes in growth pattern, leptin ghrelin and neuropeptide Y levels after adenotonsillectomy in prepubertal children.
Andiran N; Celik N; Ark N; Koca C; Kurtaran H; Karabel D
J Pediatr Endocrinol Metab; 2013; 26(7-8):683-7. PubMed ID: 23612639
[TBL] [Abstract][Full Text] [Related]
14. Does long-term use of valproate cause weight gain in prepubertal epileptic children?
Caksen H; Deda G; Berberoğlu M
Int J Neurosci; 2002 Oct; 112(10):1183-9. PubMed ID: 12587521
[TBL] [Abstract][Full Text] [Related]
15. Influence of obesity and menopausal status on serum leptin, cholecystokinin, galanin and neuropeptide Y levels.
Milewicz A; Bidzińska B; Mikulski E; Demissie M; Tworowska U
Gynecol Endocrinol; 2000 Jun; 14(3):196-203. PubMed ID: 10923281
[TBL] [Abstract][Full Text] [Related]
16. Weight and fat distribution in patients taking valproate: a valproate-discordant gender-matched twin and sibling pair study.
Petty SJ; Kantor S; Lawrence KM; Berkovic SF; Collins M; Hill KD; Makovey J; Sambrook PN; O'Brien TJ; Wark JD
Epilepsia; 2014 Oct; 55(10):1551-7. PubMed ID: 25124647
[TBL] [Abstract][Full Text] [Related]
17. Circulating acylated and total ghrelin and galanin in children with insulin-treated type 1 diabetes: relationship to insulin therapy, metabolic control and pubertal development.
Celi F; Bini V; Papi F; Santilli E; Ferretti A; Mencacci M; Berioli MG; De Giorgi G; Falorni A
Clin Endocrinol (Oxf); 2005 Aug; 63(2):139-45. PubMed ID: 16060906
[TBL] [Abstract][Full Text] [Related]
18. Serum insulin and leptin levels in valproate-associated obesity.
Pylvänen V; Knip M; Pakarinen A; Kotila M; Turkka J; Isojärvi JI
Epilepsia; 2002 May; 43(5):514-7. PubMed ID: 12027912
[TBL] [Abstract][Full Text] [Related]
19. Valproate sodium enhances body weight gain in patients with childhood epilepsy: a pathogenic mechanisms and open-label clinical trial of behavior therapy.
Kanemura H; Sano F; Maeda Y; Sugita K; Aihara M
Seizure; 2012 Sep; 21(7):496-500. PubMed ID: 22694920
[TBL] [Abstract][Full Text] [Related]
20. Plasma leptin, neuropeptide Y (NPY) and galanin concentrations in bulimia nervosa and in anorexia nervosa.
Baranowska B; Wolinska-Witort E; Wasilewska-Dziubinska E; Roguski K; Chmielowska M
Neuro Endocrinol Lett; 2001 Oct; 22(5):356-8. PubMed ID: 11600878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
